CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, announced today that CV…

Click here to view original post